Turning science into business: AnĀ optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
AT : The major interest we see is in the targeted delivery of therapeutic molecules. We are working with partners to develop delivery vehicles for small molecule payloads as next-generation precision chemotherapy and supporting partners with targeted delivery and cell penetration for gene therapies.
Let's personalize your content